Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Invested Capital (2021 - 2022)

Atea Pharmaceuticals has reported Return on Invested Capital over the past 2 years, most recently at 0.05% for Q3 2022.

  • Quarterly results put Return on Invested Capital at 0.05% for Q3 2022, changed 0.0% from a year ago — trailing twelve months through Sep 2022 was 0.05% (changed 0.0% YoY), and the annual figure for FY2021 was 0.19%, changed.
  • Return on Invested Capital for Q3 2022 was 0.05% at Atea Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AVIR hit a ceiling of 0.19% in Q4 2021 and a floor of 0.02% in Q2 2022.